BLA accepted for Priority Review Finerenone (Bayer) Nonsteroidal mineralocorticoid receptor antagonist Treatment of adult patients with heart failure with mildly reduced or preserved ejection fraction ...

The Heart Failure Drugs Market is poised for a transformative decade between 2025 and 2035. As heart failure continues to ...

Researchers have established that both diabetes mellitus (DM) and albuminuria are prevalent in heart failure with preserved ...

Researchers have discovered in a study published in JAMA Cardiology that finerenone offers stable benefits in heart failure ...